Jinyu Bio-technology Co., Ltd.

Shanghai Stock Exchange 600201.SS

Jinyu Bio-technology Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2023: USD 53.13 M

Jinyu Bio-technology Co., Ltd. Total Non-Current Liabilities is USD 53.13 M for the year ending December 31, 2023, a -3.76% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.

Jinyu Bio-technology Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2022 was USD 55.20 M, a -1.07% change year over year.
Jinyu Bio-technology Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2021 was USD 55.80 M, a 8.46% change year over year.
Jinyu Bio-technology Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2020 was USD 51.45 M, a 112.26% change year over year.
Jinyu Bio-technology Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2019 was USD 24.24 M, a 12.21% change year over year.

Key data

Date	Total Non-Current Liabilities	Shareholders' Equity	Other Liabilities	Total Liabilities

Shanghai Stock Exchange: 600201.SS

Jinyu Bio-technology Co., Ltd.

CEO	Ms. Jing Zhang
IPO Date	Jan. 15, 1999
Location	China
Headquarters	No. 1, Jinyu Street
Employees	1,654
Sector	Consumers Staples
Industries Pet Food Agriculture Biotechnology Meat Personal Care Pharmaceuticals Vaccines

Description

Jinyu Bio-technology Co., Ltd. engages in the research and development, production, and sales of veterinary biological products in China. It offers vaccines for foot-and-mouth disease, highly pathogenic avian influenza, brucellosis, rabies, and swine fever for pigs, poultry, ruminants, and pets. The company was formerly known as Inner Mongolia Jinyu Group Co., Ltd. and changed its name to Jinyu Bio-technology Co., Ltd. in December 2015. Jinyu Bio-technology Co., Ltd. was founded in 1992 and is based in Hohhot, China.

Key trends

Past 5 years